On Wednesday, the World Health Organization (WHO) said that preliminary evidence appears to indicate that vaccines may be less effective against infection and transmission linked to the Omicron variant of Sars-CoV-2, which also carries a “higher risk of re-infection”
On Wednesday, the World Health Organization (WHO) said that preliminary evidence appears to indicate that vaccines may be less effective against infection and transmission linked to the Omicron variant of Sars-CoV-2, which also carries a “higher risk of re-infection”. According to data compiled by GISAID, a global science initiative that provides open-access to genomic data of influenza viruses, a total of 60 countries have so far submitted to it sequencing data that shows the presence of this highly mutated variant on their shores.